These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9330458)

  • 1. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting.
    Chambers TJ; Tsai TF; Pervikov Y; Monath TP
    Vaccine; 1997 Oct; 15(14):1494-502. PubMed ID: 9330458
    [No Abstract]   [Full Text] [Related]  

  • 2. From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.
    Brandt WE
    J Infect Dis; 1990 Sep; 162(3):577-83. PubMed ID: 1696952
    [No Abstract]   [Full Text] [Related]  

  • 3. Concepts of control of Japanese encephalitis and dengue.
    Shope RE
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 2():131-4. PubMed ID: 9561649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines aplenty.
    Halstead SB
    Curr Opin Infect Dis; 2002 Oct; 15(5):461-3. PubMed ID: 12686876
    [No Abstract]   [Full Text] [Related]  

  • 5. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of new vaccines against dengue fever and Japanese encephalitis.
    Kinney RM; Huang CY
    Intervirology; 2001; 44(2-3):176-97. PubMed ID: 11509879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue virus and Japanese encephalitis virus epidemiological shifts in Nepal: a case of opposing trends.
    Dumre SP; Shakya G; Na-Bangchang K; Eursitthichai V; Rudi Grams H; Upreti SR; Ghimire P; KC K; Nisalak A; Gibbons RV; Fernandez S
    Am J Trop Med Hyg; 2013 Apr; 88(4):677-80. PubMed ID: 23419366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the World Health Organization. Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses.
    Brandt WE
    J Infect Dis; 1988 May; 157(5):1105-11. PubMed ID: 2452218
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
    Ishikawa T; Yamanaka A; Konishi E
    Vaccine; 2014 Mar; 32(12):1326-37. PubMed ID: 24486372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flavivirus infections: yellow fever, dengue fever and Japanese encephalitis].
    Buhl MR
    Ugeskr Laeger; 2005 Oct; 167(43):4076-80. PubMed ID: 16251091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Japanese encephalitis by inactivated vaccines.
    Hoke CH; Nisalak A; Sangawhipa N; Jatanasen S; Laorakapongse T; Innis BL; Kotchasenee S; Gingrich JB; Latendresse J; Fukai K
    N Engl J Med; 1988 Sep; 319(10):608-14. PubMed ID: 2842677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.
    Huang CY; Butrapet S; Tsuchiya KR; Bhamarapravati N; Gubler DJ; Kinney RM
    J Virol; 2003 Nov; 77(21):11436-47. PubMed ID: 14557629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dengue, a growing problem of health in the Americas].
    Kourí G
    Rev Panam Salud Publica; 2006 Mar; 19(3):143-5. PubMed ID: 16640842
    [No Abstract]   [Full Text] [Related]  

  • 15. Japanese encephalitis and dengue vaccines.
    Barrett AD
    Biologicals; 1997 Mar; 25(1):27-34. PubMed ID: 9167006
    [No Abstract]   [Full Text] [Related]  

  • 16. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 17. Tropical diseases. Hunt for dengue vaccine heats up as the disease burden grows.
    Normile D
    Science; 2007 Sep; 317(5844):1494-5. PubMed ID: 17872423
    [No Abstract]   [Full Text] [Related]  

  • 18. Flaviviruses and flavivirus vaccines.
    Heinz FX; Stiasny K
    Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: the challenge of dengue vaccine development and introduction.
    Deen JL
    Trop Med Int Health; 2004 Jan; 9(1):1-3. PubMed ID: 14728601
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.